Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maja Kalbarczyk"'
Autor:
Constanze Slabik, Maja Kalbarczyk, Simon Danisch, Reinhard Zeidler, Frank Klawonn, Valery Volk, Nicole Krönke, Friedrich Feuerhake, Constanca Ferreira de Figueiredo, Rainer Blasczyk, Henning Olbrich, Sebastian J. Theobald, Andreas Schneider, Arnold Ganser, Constantin von Kaisenberg, Stefan Lienenklaus, Andre Bleich, Wolfgang Hammerschmidt, Renata Stripecke
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 504-524 (2020)
Epstein-Barr virus (EBV) is a latent and oncogenic human herpesvirus. Lytic viral protein expression plays an important role in EBV-associated malignancies. The EBV envelope glycoprotein 350 (gp350) is expressed abundantly during EBV lytic reactivati
Externí odkaz:
https://doaj.org/article/2fc8de586f414bb99c562beadaeda7fb
Autor:
Valery Volk, Sebastian J. Theobald, Simon Danisch, Sahamoddin Khailaie, Maja Kalbarczyk, Andreas Schneider, Julia Bialek-Waldmann, Nicole Krönke, Yun Deng, Britta Eiz-Vesper, Anna Christina Dragon, Constantin von Kaisenberg, Stefan Lienenklaus, Andre Bleich, James Keck, Michael Meyer-Hermann, Frank Klawonn, Wolfgang Hammerschmidt, Henri-Jacques Delecluse, Christian Münz, Friedrich Feuerhake, Renata Stripecke
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Post-transplant lymphoproliferative disorder (PTLD) is one of the most common malignancies after solid organ or allogeneic stem cell transplantation. Most PTLD cases are B cell neoplasias carrying Epstein-Barr virus (EBV). A therapeutic approach is r
Externí odkaz:
https://doaj.org/article/5b4cfb5359cb472f97b28bdc16bb898b
Autor:
Friedrich Feuerhake, Arnold Ganser, Constantin von Kaisenberg, Nicole Krönke, Reinhard Zeidler, Constanca Figueiredo, Constanze Slabik, Wolfgang Hammerschmidt, Henning Olbrich, Rainer Blasczyk, André Bleich, Valery Volk, Frank Klawonn, Stefan Lienenklaus, Sebastian J. Theobald, Maja Kalbarczyk, Simon Danisch, Renata Stripecke, Andreas Schneider
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 504-524 (2020)
Molecular Therapy Oncolytics
Mol. Ther.-Oncolytics 18, 504-524 (2020)
Molecular therapy oncolytics
United States
Molecular Therapy Oncolytics
Mol. Ther.-Oncolytics 18, 504-524 (2020)
Molecular therapy oncolytics
United States
Epstein-Barr virus (EBV) is a latent and oncogenic human herpesvirus. Lytic viral protein expression plays an important role in EBV-associated malignancies. The EBV envelope glycoprotein 350 (gp350) is expressed abundantly during EBV lytic reactivati
Autor:
Valery, Volk, Sebastian J, Theobald, Simon, Danisch, Sahamoddin, Khailaie, Maja, Kalbarczyk, Andreas, Schneider, Julia, Bialek-Waldmann, Nicole, Krönke, Yun, Deng, Britta, Eiz-Vesper, Anna Christina, Dragon, Constantin, von Kaisenberg, Stefan, Lienenklaus, Andre, Bleich, James, Keck, Michael, Meyer-Hermann, Frank, Klawonn, Wolfgang, Hammerschmidt, Henri-Jacques, Delecluse, Christian, Münz, Friedrich, Feuerhake, Renata, Stripecke
Publikováno v:
Frontiers in Oncology
Post-transplant lymphoproliferative disorder (PTLD) is one of the most common malignancies after solid organ or allogeneic stem cell transplantation. Most PTLD cases are B cell neoplasias carrying Epstein-Barr virus (EBV). A therapeutic approach is r